Article Versions Notes

Di Nitto C, Gilardoni E, Mock J, Nadal L, Weiss T, Weller M, Seehusen F, Libbra C, Puca E, Neri D, et al. An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties. Pharmaceutics. 2023; 15(2):377. https://doi.org/10.3390/pharmaceutics15020377

Di Nitto, Cesare, Ettore Gilardoni, Jacqueline Mock, Lisa Nadal, Tobias Weiss, Michael Weller, Frauke Seehusen, Chiara Libbra, Emanuele Puca, Dario Neri, and et al. 2023. "An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties" Pharmaceutics 15, no. 2: 377. https://doi.org/10.3390/pharmaceutics15020377

Di Nitto, C., Gilardoni, E., Mock, J., Nadal, L., Weiss, T., Weller, M., Seehusen, F., Libbra, C., Puca, E., Neri, D., & De Luca, R. (2023). An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties. Pharmaceutics, 15(2), 377. https://doi.org/10.3390/pharmaceutics15020377